Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review

Central nervous system (CNS) infections constitute a life-threatening condition, especially in children. Treatment limitations exist for drug-resistant CNS bacterial infections. Inadequate CNS penetration and intravenous (IV) antibiotic treatment failure represent a major clinical challenge. However...

Full description

Bibliographic Details
Main Authors: Ibrahim Alnaami, Zubaidah Alahmari
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Tropical Medicine and Infectious Disease
Subjects:
Online Access:https://www.mdpi.com/2414-6366/7/3/41
_version_ 1797441263367094272
author Ibrahim Alnaami
Zubaidah Alahmari
author_facet Ibrahim Alnaami
Zubaidah Alahmari
author_sort Ibrahim Alnaami
collection DOAJ
description Central nervous system (CNS) infections constitute a life-threatening condition, especially in children. Treatment limitations exist for drug-resistant CNS bacterial infections. Inadequate CNS penetration and intravenous (IV) antibiotic treatment failure represent a major clinical challenge. However, patients with antibiotic-resistant bacterial CNS infections may benefit from intrathecal (IT) or intraventricular (IVT) colistin. The authors aimed to assess the safety and effectiveness of IT/IVT colistin therapy in the pediatric population, with or without other antibiotics, for the treatment of antibiotic-resistant CNS infections. A comprehensive literature search was conducted using the electronic databases of PubMed, Ovid, and Embase for relevant articles using the following terms: “Colistin”, “CNS infection”, and “Outcome”, as well as their combinations. The retrieved articles were filtered by age (Child), language (English), route of administration (IT/IVT), and species (Humans). The present systematic review comprised 20 articles that included 31 children (19; 61.2% were boys) with multidrug-resistant CNS infection. Their ages ranged from less than one month to 18 years (median: 9 months). <i>Acinetobacter baumannii</i> was the main causative organism in 22 patients (70.9%), and infection occurred mainly after neurosurgical interventions (83.8%). An external ventricular drain was inserted to administer colistin into the ventricular system in 29 cases (93.5%). The median duration for colistin therapy was 18 days. Twenty-three patients (74%) recovered, while five patients (16%) had residual disability, and three patients (10%) died. The authors concluded that IT/IVT colistin therapy is safe and effective as either the primary or adjunct treatment for antibiotic-resistant cases with CNS infection.
first_indexed 2024-03-09T12:21:31Z
format Article
id doaj.art-1c7ebfab1cfb4593b0a1e48bfb856bf5
institution Directory Open Access Journal
issn 2414-6366
language English
last_indexed 2024-03-09T12:21:31Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Tropical Medicine and Infectious Disease
spelling doaj.art-1c7ebfab1cfb4593b0a1e48bfb856bf52023-11-30T22:40:10ZengMDPI AGTropical Medicine and Infectious Disease2414-63662022-03-01734110.3390/tropicalmed7030041Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic ReviewIbrahim Alnaami0Zubaidah Alahmari1Department of Surgery, Division of Neurosurgery, King Khalid University, Abha 61421, Saudi ArabiaDepartment of Pediatric Neurosurgery, Khamis Mushait Maternity and Children Hospital, Khamis Mushait 61961, Saudi ArabiaCentral nervous system (CNS) infections constitute a life-threatening condition, especially in children. Treatment limitations exist for drug-resistant CNS bacterial infections. Inadequate CNS penetration and intravenous (IV) antibiotic treatment failure represent a major clinical challenge. However, patients with antibiotic-resistant bacterial CNS infections may benefit from intrathecal (IT) or intraventricular (IVT) colistin. The authors aimed to assess the safety and effectiveness of IT/IVT colistin therapy in the pediatric population, with or without other antibiotics, for the treatment of antibiotic-resistant CNS infections. A comprehensive literature search was conducted using the electronic databases of PubMed, Ovid, and Embase for relevant articles using the following terms: “Colistin”, “CNS infection”, and “Outcome”, as well as their combinations. The retrieved articles were filtered by age (Child), language (English), route of administration (IT/IVT), and species (Humans). The present systematic review comprised 20 articles that included 31 children (19; 61.2% were boys) with multidrug-resistant CNS infection. Their ages ranged from less than one month to 18 years (median: 9 months). <i>Acinetobacter baumannii</i> was the main causative organism in 22 patients (70.9%), and infection occurred mainly after neurosurgical interventions (83.8%). An external ventricular drain was inserted to administer colistin into the ventricular system in 29 cases (93.5%). The median duration for colistin therapy was 18 days. Twenty-three patients (74%) recovered, while five patients (16%) had residual disability, and three patients (10%) died. The authors concluded that IT/IVT colistin therapy is safe and effective as either the primary or adjunct treatment for antibiotic-resistant cases with CNS infection.https://www.mdpi.com/2414-6366/7/3/41CNS infectionchildrencolistin<i>Acinetobacter baumannii</i>intrathecalintraventricular
spellingShingle Ibrahim Alnaami
Zubaidah Alahmari
Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
Tropical Medicine and Infectious Disease
CNS infection
children
colistin
<i>Acinetobacter baumannii</i>
intrathecal
intraventricular
title Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
title_full Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
title_fullStr Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
title_full_unstemmed Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
title_short Intrathecal/Intraventricular Colistin for Antibiotic-Resistant Bacterial CNS Infections in Pediatric Population: A Systematic Review
title_sort intrathecal intraventricular colistin for antibiotic resistant bacterial cns infections in pediatric population a systematic review
topic CNS infection
children
colistin
<i>Acinetobacter baumannii</i>
intrathecal
intraventricular
url https://www.mdpi.com/2414-6366/7/3/41
work_keys_str_mv AT ibrahimalnaami intrathecalintraventricularcolistinforantibioticresistantbacterialcnsinfectionsinpediatricpopulationasystematicreview
AT zubaidahalahmari intrathecalintraventricularcolistinforantibioticresistantbacterialcnsinfectionsinpediatricpopulationasystematicreview